VERPA
VRTX icon

Virginia Estate & Retirement Planning Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Virginia Estate & Retirement Planning Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Hold
27
– – 0.02% 109
2026
Q1 		$12.1K Buy
+27
New +$12.6K 0.02% 88

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Virginia Estate & Retirement Planning Advisors's VRTX Position: Q2 2026 in Review

Virginia Estate & Retirement Planning Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 27 shares worth $13.4K. The position accounts for 0.02% of the portfolio, ranked #109.

Virginia Estate & Retirement Planning Advisors first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,730 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Virginia Estate & Retirement Planning Advisors held 27 shares of Vertex Pharmaceuticals worth $13.4K as of Q2 2026.
  • Virginia Estate & Retirement Planning Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.02% of Virginia Estate & Retirement Planning Advisors's portfolio in Q2 2026, its #109 holding.
  • Virginia Estate & Retirement Planning Advisors first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 1,730 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Virginia Estate & Retirement Planning Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.